Matthew Eley represents clients in a variety of antitrust matters. His practice includes complex civil antitrust litigation and assisting clients with government review of mergers and acquisitions.
Before joining Arnold & Porter, Matthew worked closely with the U.S. Department of Justice Criminal Division's Money Laundering and Asset Recovery Section.
Experience
- Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
Credentials
Education
- J.D., Boston University School of Law, 2019, Edward F. Hennessey Distinguished Scholar
- B.A., Chinese, Brigham Young University, 2013
Admissions
- District of Columbia
- New York
- California
- U.S. Court of Appeals for the Tenth Circuit